業績

{ 16件 }

Usui J, Kawashima S, Sada K, Miyawaki Y, Nakazawa D,.. Narita I, et al.

A digest of the evidence-based Clinical Practice Guideline for Rapidly Progressive Glomerulonephritis 2020.

Clin Exp Nephrol. 2021 Sep 26.  doi: 10.1007/s10157-021-02096-7.

IF: 2.8

  • 2021
  • 腎臓グループ
  • 欧文論文/総説

令和2年度北海道大学医学部エクセレント・ティーチャー(優秀賞) 中沢 大悟先生

  • 2021
  • 腎臓グループ
  • 受賞

Nakazawa D and Kudo T.
Novel Therapeutic Strategy Based on Neutrophil Subset and Its Function in Autoimmune Disease.
Front. Pharmacol, 07 June 2021 https://doi.org/10.3389/fphar.2021.684886
IF; 4.225 

  • 2021
  • 腎臓グループ
  • 欧文論文/総説

Anders HJ and Nakazawa D

'Being an ADVOCATE for People with ANCA Vasculitis

Clinical Journal of the American Society of Nephrology, in press.

IF: 6.628

  • 2021
  • 腎臓グループ
  • 欧文論文/原著

Watanabe-Kusunoki K, Kato M, Oki Y, Shimizu T, Kusunoki Y, Furukawa S, Furukawa S, Kitagawa H, Sakai K.

Parallel disease activity of Behçets disease with renal and entero

involvements: A case report.

BMC Nephrology. in press.

  • 2021
  • 腎臓グループ
  • 欧文論文/症例報告
  • 2020
  • 腎臓グループ

Watanabe-Kusunoki K, Nakazawa D, Ishizu A, Atsumi T. Thrombomodulin as a physiological modulator of intravascular injury. Frontiers in Immunology (in press)

IF5.085 (2019)

  • 2020
  • 腎臓グループ
  • 欧文論文/原著

Nakazawa D and Ishizu A.

Immunothrombosis in Severe COVID-19.

EBioMedicine. in press

IF 6.490

 

  • 2020
  • 腎臓グループ
  • 欧文論文/総説
  • 2019
  • 腎臓グループ

Watanabe-Kusunoki K, Nakazawa D, Kusunoki Y, Kudo T, Hattanda F, Nishio S, Masuda S, Tomaru U, Kondo T, Atsumi T, Ishizu A.

Recombinant thrombomodulin ameliorates autoimmune vasculitis via immune response regulation and tissue injury protection.
Journal of Autoimmunity. 2019. PMID: 31883830

  • 2019
  • 腎臓グループ
  • 欧文論文/原著